Florida Cancer Specialists & Research Institute, 100 Highland Avenue — Largo, Florida

Florida Cancer Specialists & Research Institute, 100 Highland Avenue is a clinical research site located in Largo, Florida, United States 33770.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Florida Cancer Specialists & Research Institute, 100 Highland Avenue has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Gilead Sciences.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Largo

Browse all research sites in Florida · View every site in Largo

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Florida Cancer Specialists & Research Institute, 100 Highland Avenue?

Florida Cancer Specialists & Research Institute, 100 Highland Avenue has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Florida Cancer Specialists & Research Institute, 100 Highland Avenue conducted?

Florida Cancer Specialists & Research Institute, 100 Highland Avenue has 1 clinical trials on record. Their work covers Breast Cancer.

Is Florida Cancer Specialists & Research Institute, 100 Highland Avenue accredited by Crixeo Clinical Trials?

Florida Cancer Specialists & Research Institute, 100 Highland Avenue has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Florida Cancer Specialists & Research Institute, 100 Highland Avenue?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.